Lisocabtagene Maraleucel
Apr 17, 2020
CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities
As per DelveInsight, the CAR T-Cell Therapy Market size for Non-Hodgkin lymphoma in the 6MM (the US, EU5 (the UK, Germany, France, Italy and Spain)) is expected to be USD 2796.2 Million by 2030. During the course of past decades, with the advancement in technology and a clear understanding of the molecular patho...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
